1-[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4-yl]methanamine hydrochloride

1-[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4-yl]methanamine hydrochloride Struktur
2173992-07-7
CAS-Nr.
2173992-07-7
Englisch Name:
1-[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4-yl]methanamine hydrochloride
Synonyma:
[4-(aminomethyl)-4-fluoro-1-piperidyl]-(3-chloro-4-fluoro-phenyl)methanone;1-[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4-yl]methanamine hydrochloride;4-(Aminomethyl)-4-fluoropiperidin-1-yl](3-chloro-4-fluorophenyl)methanone Hydrochloride
CBNumber:
CB54902343
Summenformel:
C13H16Cl2F2N2O
Molgewicht:
325.1817464
MOL-Datei:
2173992-07-7.mol

1-[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4-yl]methanamine hydrochloride Eigenschaften

Sicherheit

1-[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4-yl]methanamine hydrochloride Chemische Eigenschaften,Einsatz,Produktion Methoden

1-[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4-yl]methanamine hydrochloride Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1-[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4-yl]methanamine hydrochloride Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aceschem Inc.
+1-817863-6948 +1-(817)863-6948
sales@aceschem.com United States 19639 58
Suzhou ARTK Medchem Co., Ltd.
+86-512-68323967 +86-18015559028
sales1@artkmedchem.com China 39009 58
Wuhan chuang he chemical co. LTD 15907120073
1261789306@qq.com China 955 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188
sun_dan@PharmaBlock.com China 7268 58
Shaoyuan Technology (Shanghai) Co., Ltd. 021-50795510 4000665055
sy-c6@accelachem.com China 10188 58

  • 1-[1-(3-chloro-4-fluorobenzoyl)-4-fluoropiperidin-4-yl]methanamine hydrochloride
  • [4-(aminomethyl)-4-fluoro-1-piperidyl]-(3-chloro-4-fluoro-phenyl)methanone
  • 4-(Aminomethyl)-4-fluoropiperidin-1-yl](3-chloro-4-fluorophenyl)methanone Hydrochloride
  • 2173992-07-7
Copyright 2019 © ChemicalBook. All rights reserved